{"disease":{"id":"h1n1-influenza","name":"h1n1 influenza"},"drugs":{"marketed":[{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-modrna-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in individuals 6 months of age and older, when the same vaccine virus strains are circulating","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quadrivalent influenza modRNA vaccine","generic_name":"quadrivalent-influenza-modrna-vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza virus","drug_class":"Vaccine","quality_score":52,"revenue":null,"mechanism":"This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses."},{"drug_id":"quadrivalent-influenza-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in people 6 months of age and older","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Quadrivalent Influenza Vaccine","company_name":"International Centre for Diarrhoeal Disease Research, Bangladesh","drug_phase":"marketed","molecular_target":"Influenza viruses","drug_class":"Inactivated vaccine","quality_score":34,"revenue":null,"mechanism":"This vaccine works by stimulating the body's immune system to produce antibodies against influenza viruses."},{"drug_id":"quadrivalent-influenza-vaccine","indication_name":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in people 6 months of age and older, when the circulating influenza A and B viruses are expected to be well matched to the vaccine viruses.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Quadrivalent Influenza Vaccine","company_name":"International Centre for Diarrhoeal Disease Research, Bangladesh","drug_phase":"marketed","molecular_target":"Influenza viruses","drug_class":"Inactivated vaccine","quality_score":34,"revenue":null,"mechanism":"This vaccine works by stimulating the body's immune system to produce antibodies against influenza viruses."},{"drug_id":"qiv","indication_name":"Prevention of influenza A virus, A(H1N1)pdm09, A(H3N2), and influenza B viruses","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Qiv","generic_name":"qiv","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Influenza viruses","drug_class":"Inactivated vaccine","quality_score":37,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":54,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04933994","title":"Comparison of COVID-19 and H1N1 Influenza Pneumonia","phase":"","overall_status":"COMPLETED","enrollment_count":483,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT05080933","title":"ECMO for COVID-19 vs Influenza A H1N1 Associated ARDS","phase":"","overall_status":"COMPLETED","enrollment_count":308,"lead_sponsor_name":"University of Turin, Italy","has_results":false},{"nct_id":"NCT02371668","title":"Efficacy and Safety of CR6261 in an H1N1 Influenza Healthy Volunteer Human Challenge Model","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":104,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT04497311","title":"Tomographic Findings in COVID-19 and Influenza","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Universidad de Guanajuato","has_results":false},{"nct_id":"NCT03641690","title":"Serum and Bronchoalveolar Inflammatory Parameters in Patients With Severe Adult Respiratory Distress Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"Centre Hospitalier Universitaire, Amiens","has_results":false},{"nct_id":"NCT04810949","title":"Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml","phase":"NA","overall_status":"TERMINATED","enrollment_count":41,"lead_sponsor_name":"Hospital Clinica Nova","has_results":false},{"nct_id":"NCT02921997","title":"H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}